Nutrien to Indefinitely Shut Down Trinidad Nitrogen Operations

Zacks
Apri Zacks
Nutrien to Indefinitely Shut Down Trinidad Nitrogen Operations

Nutrien Ltd. NTR announced that it will indefinitely shut down its Trinidad Nitrogen operations at the Point Lisas Facility following a comprehensive review of strategic alternatives and discussion with relevant stakeholders. The decision comes in response to ongoing natural gas constraints and supply uncertainty, and is aimed at reducing pressure to enhance its free cash flow and return on invested capital.

Nutrien previously implemented a controlled shutdown of the facility on Oct. 23, 2025, due to port access restrictions and a lack of reliable and economic natural gas supply. With these challenges in mind, the company determined that permanently halting operations would be the optimal path.

The shutdown should not affect Nutrien’s 2026 nitrogen sales volume guidance, as the company had already assumed no production from Trinidad’s operations. Nutrien remains well positioned to meet customer demand and support nitrogen volume growth through its North American operations. Reliability improvements and low-cost debottlenecking projects are expected to help increase production. The move also advances Nutrien’s focus on optimizing its portfolio, supporting the company’s long-term financial flexibility.

The company, on its second-quarter call, raised its 2026 Potash sales volume guidance to 14.2-14.8 million tons from 14.1-14.8 million tons, supported by strong demand in key offshore markets. Global potash shipments are still projected at 74-77 million tons for 2026.  Nitrogen sales volume guidance was maintained at 9.2-9.7 million tons, while Phosphate sales volume guidance remains 2.4-2.6 million tons. The Nitrogen outlook reflects planned reliability improvements and debottlenecking initiatives, while the Phosphate guidance reflects benefits from reliability improvements completed in 2025.  

NTR shares have gained 15.9% in the past year compared with the industry’s 49.4% decline in the same period.

Zacks Investment Research
Image Source: Zacks Investment Research

NTR’s Zacks Rank & Key Picks

NTR currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the Basic Materials space are Reliance, Inc. RS, Avient Corporation AVNT and Kronos Worldwide, Inc. KRO.

RS, AVNT and KRO carry a Zacks Rank #2 (Buy) each at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Zacks Consensus Estimate for RS’ 2026 earnings is pegged at $22.53 per share, indicating a 58% year-over-year increase. RS’shares have gained 45.6% over the past year.

The Zacks Consensus Estimate for AVNT’s current-year earnings is pinned at $3.2 per share, indicating a 13.5% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 3.4%. AVNT’sshares have gained 30.1% over the past year.

The Zacks Consensus Estimate for KRO’s 2026 earnings is pegged at 35 cents per share, indicating a rise of 136.5% year over year. Its earnings beat the Zacks Consensus Estimate in two of the trailing four quarters while missing it in the rest, with an average surprise of 34%.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."

Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention. 

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Nutrien Ltd. (NTR): Free Stock Analysis Report
 
Reliance, Inc. (RS): Free Stock Analysis Report
 
Kronos Worldwide Inc (KRO): Free Stock Analysis Report
 
Avient Corporation (AVNT): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research